Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

NCT07662603 · tracked via the Priya Life Science Egypt tracker

Sponsor

Cairo University

Phase

Not applicable

Started

2026-05-06

Last updated

2026-06-23

Condition(s) studied

Behcet Disease

Investigational drug(s) / intervention(s)

inspiratory muscle trianing

inspiratory muscle trianing: twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week)

Study summary

physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated

Eligibility

Sex

ALL

Min age

13 Years

Max age

17 Years

Healthy volunteers

Inclusion Criteria: * adlescent patients * complain Behcet disease * after pulmonary endoarterectomy Exclusion Criteria: * chronci cardiac diseases * psychic disease * mental disease

Primary outcome measure(s)

forced vital capacity — it will be measured after 12 weeks
it si a pulmaonry fucntion test

Trial sites (1)

Facility	City	Region	Status
Cairo University	Giza	Dokki	Recruiting

More Cairo University trials in Egypt

Effect of High Power Laser Acupuncture on Post Menopausal Hot Flashes Starting soon

Brochoscopic Intervention Versus Conventional Management in Acute Lung Collapse in the Pediatric Intensive Care Unit Active, not recruiting

Effect of Neuromuscular Electrical Stimulation on Muscle Mass in ECMO Patients Starting soon

Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery Active, not recruiting

SHAPE Versus Milligan-Morgan Hemorrhoidectomy for Hemorrhoidal Disease Recruiting

Other trials for the same condition

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease Recruiting

Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07662603 on ClinicalTrials.gov ↗ ← All trials in Egypt